Effects of CoCl2‑simulated hypoxia on the expression levels of matrix metalloproteinases in renal adenocarcinoma cells and renal tubular epithelial cells
Open Access
- 21 June 2018
- journal article
- research article
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 16 (2) , 1454-1460
Abstract
Renal cell carcinoma (RCC) and chronic kidney disease (CKD) are associated with hypoxia, but the effects of hypoxia on the process of angiogenesis in the two diseases are dramatically different. Some of matrix metalloproteinases (MMPs), such as MMP2 and MMP9, may have a role because they represent the most prominent family of proteinases associated with angiogenesis. In the present study, the differential response of human renal cell cancer cells (786‑0), human renal tubular epithelial cells (HK‑2) and human microvascular endothelial cells (HMEC‑1) to hypoxia with regards to the expression of MMP2, MMP9, MMP14, TIMP2, RECK was investigated. Cobalt chloride (CoCl2) treatment was used to simulate the hypoxia environment in RCC and CKD. The expression levels of HIF‑1α, RECK, MMP2, MMP9, MMP14 and TIMP2 in HK2, 786‑0 and HMEC‑1 cells were determined by western blot analysis after incubation with varying concentrations of CoCl2 for 24 h. It was indicated that the effects of hypoxia on the endogenous expression of RECK and MMP2 differed depending on the considered cell type. Notably, the RECK expression was significantly decreased in 786‑0 cells under hypoxia, whereas this expression was slightly increased in HK2 and HMEC‑1 cells. Furthermore, the MMP2 expression was significantly increased in HMEC‑1 cells under hypoxia, whereas the expression was slightly decreased in HK2 and 786‑0 cells. These results demonstrate that 786‑0, HK2 and HMEC‑1 cells respond differently under hypoxic conditions. Furthermore, MMP2 and RECK may serve divergent roles in HK2 and HMEC‑1 cells under hypoxic conditions.Keywords
This publication has 20 references indexed in Scilit:
- The Angiogenic Effect of microRNA-21 Targeting TIMP3 through the Regulation of MMP2 and MMP9PLOS ONE, 2016
- Matrix metalloproteinase-9 is required for vasculogenic mimicry by clear cell renal carcinoma cellsUrologic Oncology: Seminars and Original Investigations, 2015
- Matrix Metalloproteinases: Inflammatory Regulators of Cell Behaviors in Vascular Formation and RemodelingMediators of Inflammation, 2013
- MMP-9 gene deletion mitigates microvascular loss in a model of ischemic acute kidney injuryAmerican Journal of Physiology-Renal Physiology, 2011
- Morphometric and Visual Evaluation of Fibrosis in Renal BiopsiesJournal of the American Society of Nephrology, 2011
- Crucial Role of Membrane Type 1 Matrix Metalloproteinase (MT1- MMP) in RhoA/Rac1-Dependent Signaling Pathways in Thrombin- Stimulated Endothelial CellsJournal of Atherosclerosis and Thrombosis, 2011
- Hypoxia and RAS-signaling pathways converge on, and cooperatively downregulate, the RECK tumor-suppressor protein through microRNAsOncogene, 2010
- Hypoxia accelerates cancer invasion of hepatoma cells by upregulating MMP expression in an HIF-1α-independent mannerInternational Journal of Oncology, 2006
- Physiological levels of tumstatin, a fragment of collagen IV α3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via αVβ3 integrinCancer Cell, 2003
- Regulation of Endothelial Matrix Metalloproteinase-2 by Hypoxia/ReoxygenationCirculation Research, 2002